167 related articles for article (PubMed ID: 37542577)
1. Comparative proteomic investigation unravels the pathobiology of Mycobacterium fortuitum biofilm.
Sharma A; Bansal S; Kumari N; Vashistt J; Shrivastava R
Appl Microbiol Biotechnol; 2023 Oct; 107(19):6029-6046. PubMed ID: 37542577
[TBL] [Abstract][Full Text] [Related]
2. Biofilm formation and biocide susceptibility testing of Mycobacterium fortuitum and Mycobacterium marinum.
Bardouniotis E; Ceri H; Olson ME
Curr Microbiol; 2003 Jan; 46(1):28-32. PubMed ID: 12432460
[TBL] [Abstract][Full Text] [Related]
3. Biofilm formation by the rapidly growing mycobacterial species Mycobacterium fortuitum.
Hall-Stoodley L; Lappin-Scott H
FEMS Microbiol Lett; 1998 Nov; 168(1):77-84. PubMed ID: 9812366
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of the Type-II Fatty acid synthase gene
Sharma A; Vashistt J; Shrivastava R
Int J Mycobacteriol; 2022; 11(2):159-166. PubMed ID: 35775548
[TBL] [Abstract][Full Text] [Related]
5. Random insertion transposon mutagenesis of Mycobacterium fortuitum identified mutant defective in biofilm formation.
Katoch P; Gupta K; Yennamalli RM; Vashistt J; Bisht GS; Shrivastava R
Biochem Biophys Res Commun; 2020 Jan; 521(4):991-996. PubMed ID: 31727369
[TBL] [Abstract][Full Text] [Related]
6. Mycobacterium fortuitum fabG4 knockdown studies: Implication as pellicle and biofilm specific drug target.
Sharma A; Vashistt J; Shrivastava R
J Basic Microbiol; 2022 Dec; 62(12):1504-1513. PubMed ID: 35736669
[TBL] [Abstract][Full Text] [Related]
7. Decoding the proteomic changes involved in the biofilm formation of Enterococcus faecalis SK460 to elucidate potential biofilm determinants.
Suryaletha K; Narendrakumar L; John J; Radhakrishnan MP; George S; Thomas S
BMC Microbiol; 2019 Jun; 19(1):146. PubMed ID: 31253082
[TBL] [Abstract][Full Text] [Related]
8. Response surface modeling integrated microtiter plate assay for
Sharma A; Vashistt J; Shrivastava R
Biofouling; 2021 Sep; 37(8):830-843. PubMed ID: 34503352
[TBL] [Abstract][Full Text] [Related]
9. Nontuberculous mycobacteria pathogenesis and biofilm assembly.
Sousa S; Bandeira M; Carvalho PA; Duarte A; Jordao L
Int J Mycobacteriol; 2015 Mar; 4(1):36-43. PubMed ID: 26655196
[TBL] [Abstract][Full Text] [Related]
10. Mycobacterium fortuitum and Mycobacterium chelonae biofilm formation under high and low nutrient conditions.
Hall-Stoodley L; Keevil CW; Lappin-Scott HM
J Appl Microbiol; 1998 Dec; 85 Suppl 1():60S-69S. PubMed ID: 21182694
[TBL] [Abstract][Full Text] [Related]
11. Biofilms of Pathogenic Nontuberculous Mycobacteria Targeted by New Therapeutic Approaches.
Aung TT; Yam JK; Lin S; Salleh SM; Givskov M; Liu S; Lwin NC; Yang L; Beuerman RW
Antimicrob Agents Chemother; 2016 Jan; 60(1):24-35. PubMed ID: 26459903
[TBL] [Abstract][Full Text] [Related]
12. Discovery of novel antimycobacterial drug therapy in biofilm of pathogenic nontuberculous mycobacterial keratitis.
Aung TT; Chor WHJ; Yam JKH; Givskov M; Yang L; Beuerman RW
Ocul Surf; 2017 Oct; 15(4):770-783. PubMed ID: 28662943
[TBL] [Abstract][Full Text] [Related]
13. Comparative proteomics analysis between biofilm and planktonic cells of Mycobacterium tuberculosis.
Wang C; Zhang Q; Wang Y; Tang X; An Y; Li S; Xu H; Li Y; Luan W; Wang X; Liu M; Yu L
Electrophoresis; 2019 Oct; 40(20):2736-2746. PubMed ID: 31141184
[TBL] [Abstract][Full Text] [Related]
14. SDS-PAGE for identification of species belonging to the Mycobacterium fortuitum complex.
Esteban J; Molleja A; Cabria F; Soledad Jiménez M
Clin Microbiol Infect; 2003 Apr; 9(4):327-31. PubMed ID: 12667246
[TBL] [Abstract][Full Text] [Related]
15. Mycobacterium fortuitum prosthetic valve endocarditis: a case for the pathogenetic role of biofilms.
Bosio S; Leekha S; Gamb SI; Wright AJ; Terrell CL; Miller DV
Cardiovasc Pathol; 2012; 21(4):361-4. PubMed ID: 22196518
[TBL] [Abstract][Full Text] [Related]
16. Taxonomic variation in the Mycobacterium fortuitum third biovariant complex: description of Mycobacterium boenickei sp. nov., Mycobacterium houstonense sp. nov., Mycobacterium neworleansense sp. nov. and Mycobacterium brisbanense sp. nov. and recognition of Mycobacterium porcinum from human clinical isolates.
Schinsky MF; Morey RE; Steigerwalt AG; Douglas MP; Wilson RW; Floyd MM; Butler WR; Daneshvar MI; Brown-Elliott BA; Wallace RJ; McNeil MM; Brenner DJ; Brown JM
Int J Syst Evol Microbiol; 2004 Sep; 54(Pt 5):1653-1667. PubMed ID: 15388725
[TBL] [Abstract][Full Text] [Related]
17. Pathogenicity of Mycobacterium fortuitum and Mycobacterium smegmatis to goldfish, Carassius auratus.
Talaat AM; Trucksis M; Kane AS; Reimschuessel R
Vet Microbiol; 1999 Apr; 66(2):151-64. PubMed ID: 10227476
[TBL] [Abstract][Full Text] [Related]
18. Use of gas chromatographic fatty acid and mycolic acid cleavage product determination to differentiate among Mycobacterium genavense, Mycobacterium fortuitum, Mycobacterium simiae, and Mycobacterium tuberculosis.
Chou S; Chedore P; Kasatiya S
J Clin Microbiol; 1998 Feb; 36(2):577-9. PubMed ID: 9466781
[TBL] [Abstract][Full Text] [Related]
19. Ultrastructural morphologic changes in mycobacterial biofilm in different extreme condition.
Kumar V; Sachan TK; Sharma P; Rawat KD
Ultrastruct Pathol; 2015 Feb; 39(1):38-48. PubMed ID: 25192360
[TBL] [Abstract][Full Text] [Related]
20. CFTR Depletion Confers Hypersusceptibility to
Johansen MD; Kremer L
Front Cell Infect Microbiol; 2020; 10():357. PubMed ID: 32850470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
